Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3939868 | Fertility and Sterility | 2008 | 4 Pages |
Abstract
The effect of mifepristone on the expression of secretory leukocyte protease inhibitor (SLPI) in the endometrium of women using depot medroxyprogesterone acetate (DMPA) was investigated in this randomized, placebo-controlled trial. The study showed that the administration of DMPA led to a substantial inhibition of endometrial SLPI protein and mRNA, and that the addition of mifepristone to DMPA-exposed endometrium partially restored the expression of glandular SLPI.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Aimin Li, Juan C. Felix, Wangrong Yang, John K. Jain,